|
TAMPA, Fla. (Business Wire EON) June 22, 2008 --
In support of its ever growing line of unique, natural, nutraceutical
products, PanGenex Corporation (Pink Sheets: PGXC
- News) announces
the launch of a new retail and physician web platform at www.HeartHealthyWorld.com.
This announcement follows the June 6, 2008 introduction of its highly
regarded, all-natural LIPIDEME™ product which
is the first product on the market to combine the triglyceride-lowering
power of Omega-3 fatty acids with the cholesterol lowering ability of
plant sterols (phytosterols) and tocotrienols (part of the Vitamin E
family) and the enzyme CoQ10.
www.HeartHealthyWorld.com
has global capacity and creates a seamless link from a physician’s
office and retailer outlets to PanGenex fulfillment and research centers
as well as featuring the complete PanGenex product line in an easy to
navigate format. The platform has an additional component which allows
consumers to purchase product, research formulations and learn more
about living a “Heart Healthy”
lifestyle.
According to the Nutrition Business Journal’s “Supplement
Business Report”, sales of over-the-counter
nutraceuticals exceeded $68B in 2007 with an expected increase of over 3
percent in 2008.
“End user connectivity, whether in providing
product information or in order processing, is a key tenant of consumer
marketing. PanGenex has invested significant capital in developing tools
that will spread the word about our superior, pharmaceutical grade
products and at the same time make it simple and fast for interested
parties to purchase PanGenex products worldwide,”
states Jeff Roman, President and CEO of PanGenex Corporation.
* The statements in this press release have not been evaluated by the
Food and Drug Administration. This product is not intended to diagnose,
treat, cure or prevent any disease.
Visit HeartHealthyWorld.com at:
www.HeartHealthyWorld.com
About PanGenex Corporation:
PanGenex is a publicly traded corporation (PINK SHEETS: PGXC) and
pursues business opportunities in the $70 billion dollar nutraceutical
and dietary supplement industry. With a focus on the cardiovascular
health segment, PanGenex develops and markets sector leading, patented
or patent pending, condition specific nutraceuticals and topical
over-the-counter (OTC) drugs and personal care products. Each product is
scientifically formulated to address specific health conditions. Many of
our products contain the purest grade of nutraceutical components
available anywhere without a prescription. PanGenex markets products
through healthcare practitioners throughout the, retail establishments
and the internet on websites such as www.PanGenex.com
and www.HeartHealthyWorld.com.
Disclaimer:
CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS
This press release contains "forward-looking statements," which are
statements related to future, not past, events. In this context, the
forward-looking statements often include statements regarding our goals,
plans, projections and guidance regarding our financial position,
results of operations, market position, pending and potential future
acquisitions and business strategy, and often contain words such as
"expects," "anticipates," "intends," "plans," "believes," "seeks" or
"will." Any such forward-looking statements are not assurances of future
performance and involve risks and uncertainties that may cause results
to differ materially from those set forth in the statements. These risks
and uncertainties include, among other things, (a) general economic and
business conditions, (b) the level of strategic partner incentives, (c)
the future regulatory environment, (d) our cost of financing, (e) our
ability to complete acquisitions and dispositions and the risks
associated therewith, and (f) our ability to retain key personnel. These
factors, as well as additional factors, could affect our forward-looking
statements. We urge you to carefully consider this information. We
undertake no duty to update our forward-looking statements, including
our earnings outlook. The statements in this press release have not been
evaluated by the Food and Drug Administration. This product is not
intended to diagnose, treat, cure or prevent any disease.
Post Comment:
Trackback URL: http://eon.businesswire.com/pingpr.php/WmV0YS1QaWdnLUluc2UtUHJvZi1Qcm9mLVplcm8=
Bookmark -
Del.icio.us |
Digg |
Furl It |
Spurl |
RawSugar |
Simpy |
Shadows |
Blink It |
My Web
|
